think about Pfizer & Moderna...studies and time frame

Discussion in 'Johnson & Johnson' started by anonymous, Feb 18, 2021 at 7:20 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    One thing to keep in mine when they were doing their "trials" less people in the general population had covid, so it was harder for pts. who got the shot to be around a high number of infected people. Also the Placebo, group also back then, they were not around as many people.....so you guessed the numbers look a lot better.

    So, if they did the trials when J&J did them, they would have a lot less of a success rate. This is like comparing Apples to Oranges....

    Get it????
     

  2. anonymous

    anonymous Guest

    got it bro
     
  3. anonymous

    anonymous Guest

    Correct. Combine this with ours only needing 1 dose and I think we’re in a good spot.
     
  4. anonymous

    anonymous Guest

    One dose, that is great. This will do just fine. I started this post.
     
  5. anonymous

    anonymous Guest

    Nope. When the infection rates dropped so much in summer 2020, Pfizer expanded trials into Argentina and Brazil which were blazing hot. Overall number of infections in the placebo groups were similar among all vaccines in phase 3 when they did interim analysis. Get it????
     
  6. anonymous

    anonymous Guest

    This comment aged like schmegma in panties.